Eosinophilic Esophagitis (EE) Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Eosinophilic Esophagitis Program

Boston Children’s Hospital is home to the world’s most extensive research enterprise at a pediatric hospital. We also have many partnerships with research, biotech and health care organizations, and we work together to find innovative ways to improve kids’ health.

The Eosinophilic Gastrointestinal Disease (EGID) Program joins several other centers of excellence within the Division of Gastroenterology, Hepatology and Nutrition, including those for IBD, liver disease, celiac disease, clinical nutrition, motility and functional gastrointestinal disorders and endoscopy. The Division of Allergy and Immunology cares for more than 6,000 children in New England, as well as children with rare immunodeficiencies from around the world.

While we are learning more about the cause and treatment of EGIDs, much remains uncertain. The EGID Program at Children’s is actively involved in cutting-edge research with basic science, clinical and translational studies, including investigating ways to recognize the presence of eosinophils without having to do an endoscopy.

You may be offered the opportunity to participate in a study. Please know that while conducting research is a very important mission of our program, your child’s care in the EGID Program will never be compromised should you decline to participate.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close